Capillary Technologies India Ltd. — Q2 and H1 FY27 — 2 November 2026

1. Overall Tone of Management

Optimistic, with meaningful qualifications. Management emphasized strong revenue, ARR, ACV and EBITDA growth, described momentum in Aira and new business as “very good,” and said it expected to meet or slightly exceed guidance. The confidence is tempered by a stated need to hold to 20% organic growth guidance for several more quarters before claiming acceleration, a possible delay in Aira’s ARR target, and multi-year migration timelines for acquired customers.

2. Key Themes from Management Commentary

Growth across existing and new customers: Organic NRR was about 116% (constant-currency NRR about 109%). New ACV increased to ₹93 crore on a trailing-12-month basis, versus ₹52 crore a year earlier. Management attributed stronger new wins in part to Aira’s differentiation.
Acquisitions are a large part of reported growth: H1 revenue grew 47% year on year; organic revenue grew 23%, while inorganic revenue more than doubled, largely due to SessionM. Management said SessionM was at break-even in both Q1 and Q2.
Margins and operating leverage: Gross margin remained 67% despite SessionM’s lower margin. Adjusted EBITDA margin rose to 17% in Q2 and H1, versus 11% in H1 FY26. Management said margins should benefit from organic expansion, cost discipline and acquired-business efficiencies.
Aira is expanding beyond loyalty analytics: The product now connects to paid acquisition channels such as Google Ads, Meta, TikTok and Amazon Ads. Capillary has also launched a standalone sales motion for Aira, opening a route to non-Capillary customers.
Acquired-platform cost reduction may precede migration: SessionM’s server costs are being addressed through infrastructure changes, including a planned reduction of roughly 50% by March/April. Full customer migrations remain a 2–3-year process.
Agentic commerce is framed as a product opportunity: Management believes more rational shopping agents could make promotions, points and real-time platform performance more important—though the commercial implications remain prospective.

3. Q&A Analysis

Aira product, monetization and growth

Analysts asked: What the new acquisition-channel integrations do; Aira’s run rate, deal sizes and pipeline; whether Aira can be sold independently; and whether its $10 million ARR year-end objective remains achievable.
Management responded: Aira analyzes campaign data across platforms and recommends or supports changes; it is “not the ad tech platform” but an intelligence layer. Average deal sizes were cited at roughly $100,000–$200,000, with an $8–9 million pipeline. Aira can sit on data lakes such as Databricks, Snowflake or BigQuery, and a separate sales motion has launched.
Caveat: Management said the $10 million objective “might be delayed by a quarter” but remained achievable. The call did not provide a fresh Aira ARR figure, so pipeline should not be confused with booked revenue.
Historical context: In Q1, management cited a $2–2.5 million run rate and hoped Aira could reach 5–10% of company revenue during FY27.

SessionM economics, server costs and migrations

Analysts asked: Why acquired customers do not all migrate; how SessionM’s unusually high server costs will fall; and when margin benefits will appear.
Management responded: Historical post-migration revenue retention was 66–70%, with about 80–85% willingness to migrate after excluding customer bankruptcies. SessionM’s gross margin was reported at 51–52%, versus about 70% for Capillary’s core platform. Management expects SessionM server costs to fall by about 50% by March/April, with further gains as customers migrate over 2–3 years.
Strong/qualified answer: Management gave concrete cost targets and acknowledged the long migration timetable. But these are future targets, not yet demonstrated outcomes. It also said meaningful savings can begin before migration, so investors will need to distinguish operating-cost actions from actual platform conversions.
Historical context: Q1 said SessionM migration would not meaningfully start until late FY27/early FY28, with bulk migrations in FY28–FY29. The current call broadly maintains that timetable while emphasizing earlier cost savings.

Organic growth, new ACV and deal size

Analysts asked: Whether new ACV growth can continue without another unusually large healthcare contract, and whether organic growth is accelerating.
Management responded: The large healthcare deal was not considered repeatable at that size; other large deals are possible, but not regularly at the same scale. Management cited stronger deal velocity across Europe, Southeast Asia and India, while the US was broadly similar to last year.
Caution: Despite strong ACV momentum, management said it would keep to 20% organic growth guidance for a few more quarters before declaring a sustained acceleration. The new ACV growth figures were presented with differing bases and exclusions during the call, so comparisons require care.
Historical context: Q1 cited 75% growth in trailing-12-month new ACV excluding the large healthcare customer and described full-year organic growth as roughly 17% including currency effects.

Gross margin and financial performance

Analysts asked: How SessionM affected gross margins, and how much new ACV came from new logos versus existing-customer expansion.
Management responded: Core Capillary gross margin was about 70%, SessionM about 51–52%, and the combined margin about 67%. Of trailing-12-month ACV of ₹93 crore, management estimated 35–40% from new logos, with the rest mainly from farming existing customers.
Partial answer: The company did not initially have the exact margin split at hand, but supplied it later in the Q&A.

M&A strategy and valuation discipline

Analysts asked: Whether more acquisitions are planned and how Capillary weighs acquisition economics against organic customer wins.
Management responded: The M&A team remains active, but the company wants appropriate valuations, good retention and a 4–5-year or shorter payback. Management said it would not pursue deals that fail those tests.
Signal: The acquisition playbook remains central, but management did not identify a specific pipeline deal.

4. Guidance / Outlook

Quantitative guidance

FY27 company guidance: Management said it expects to achieve or slightly exceed the guidance set at the start of the year. The prior call cited figures of ₹1,065 crore revenue and ₹172 crore adjusted EBITDA; no revised targets were provided on this call.
Organic growth: Management reiterated 20% organic growth guidance, saying it would remain within that range for at least a few more quarters before assessing whether growth has structurally accelerated.
Aira: The previously discussed $10 million ARR objective may be delayed by one quarter, though management still considers it achievable.
SessionM costs: Management expects server costs to decline by roughly 50% by March/April. This is a target, not a reported achievement.
Migration timing: SessionM customer migration is expected to take 2–3 years; Cognitiv and other migrations are also expected to contribute progressively.

Qualitative signals

Management described new-business momentum as strong, but did not yet translate it into higher organic growth guidance.
It expects acquired-customer value to emerge through a combination of server-cost reduction, reduced support burden, migration and product upsell.
Further M&A remains possible, subject to valuation and retention discipline.
Management cited headcount growth of 4–5% against revenue growth above 40%, while noting that acquired teams are being redeployed. This suggests continued operating leverage, but the comparison is not a standalone organic hiring plan.

5. Standout Statements

“We definitely think we will achieve the guidance or do slightly better.”
“For now, I would say that we should remain within the guidance we have provided—20% organic growth—for at least a few more quarters.”
“It might be delayed by a quarter, but I do think the [Aira] objective is achievable.”
“There are approximately 40 customers on that book… It will probably migrate over 2 or 3 years.”
“We think the server costs will come down by approximately 50% by March or April.”
On agentic commerce: “An agent is not lazy.” Management argued that agents may make loyalty benefits and promotions more directly relevant to purchase decisions.

6. Red Flags / Positive Signals

Red flags
– Organic growth guidance was not raised despite strong ACV growth; management explicitly asked investors to wait before concluding that acceleration is durable.
– Aira’s $10 million ARR target may slip, and management did not provide a current ARR update.
– SessionM cost reductions and migration benefits are still prospective; complete migration takes years.
– Reported H1 growth is materially acquisition-driven: inorganic revenue more than doubled while organic growth was 23%.
– Q2 reported PAT was ₹22 crore, while H1 PAT was ₹12 crore, reflecting the weak Q1 reported result; the transcript does not fully reconcile the quarter-to-half-year picture in the narrative.

Positive signals
– Organic NRR of about 116%; trailing-12-month new ACV rose to ₹93 crore.
– Adjusted EBITDA margin reached 17% in Q2 and H1, with gross margin holding at 67% despite SessionM.
– SessionM reached break-even in both Q1 and Q2.
– Management said Aira’s pipeline is $8–9 million and that it has launched a standalone sales motion.

7. Historical Comparison & Consistency Analysis

Quarter-by-Quarter Tone Evolution

Third-last transcript — period unavailable
– Dominant tone: Not assessable
– Major themes this quarter: Transcript not available; no period or management commentary can be verified.
– Tone shift vs previous quarter: N/A (baseline)
– What changed: No usable transcript provided.

Q4 FY26 — 6 May 2026
– Dominant tone: Optimistic
– Major themes this quarter:
– FY26 revenue grew 23%; adjusted EBITDA margin reached 14.7%.
– SessionM acquisition was presented as a growth and customer-access opportunity.
– Organic NRR was 114%; inorganic NRR was 94% amid acquired-customer migrations.
– Management introduced AI-led migration as a way to accelerate acquired-platform upgrades.
– Tone shift vs previous quarter: N/A (baseline among usable transcripts)
– What changed: Baseline. Management laid out substantial FY27 revenue expectations and an acquisition-led margin opportunity, while acknowledging that SessionM would initially contribute little margin.

Q1 FY27 — 4 August 2026
– Dominant tone: Optimistic
– Major themes this quarter:
– 43% reported revenue growth and 17% adjusted EBITDA margin.
– SessionM was at break-even; the company said acquired customers were interested in Aira.
– Aira was at a stated $2–2.5 million run rate, with hopes for 5–10% of FY27 revenue.
– First Kognitiv customer migration was expected to go live on 1 September.
– Tone shift vs previous quarter: No Change
– What changed:
– Management became more specific on the near-term SessionM operating case and said FY27 revenue and EBITDA should exceed ₹1,065 crore and ₹172 crore.
– AI-led migration was presented as a faster path, with an 18–24-month Kognitiv upgrade ambition.
– The call also disclosed a cyber-fraud loss, described as insured but with recovery amount and timing unclear.

Q2 / H1 FY27 — 2 November 2026
– Dominant tone: Optimistic
– Major themes this quarter:
– Strong H1 growth and 17% adjusted EBITDA margin.
– New ACV and organic NRR remained strong; management linked wins to Aira.
– SessionM cost reductions and migrations were positioned as future margin levers.
– Aira expanded into advertising-channel analytics and standalone selling.
– Tone shift vs previous quarter: More Cautious
– What changed:
– Management resisted raising organic-growth expectations, reiterating 20% guidance pending more evidence.
– Aira’s $10 million ARR objective was acknowledged as potentially one quarter late.
– SessionM migration was described as a 2–3-year process, with early savings dependent on cost actions still underway.

Trajectory Summary: The narrative has remained upbeat, but the source of confidence has shifted from FY26 operating leverage and acquisition synergies toward Aira-led wins and future SessionM efficiencies. Q2 is more measured than Q1 on the timing of organic acceleration and Aira monetization; management is increasingly explicit that acquired-platform benefits will take time.

Tracking Past Commitments vs Outcomes

SessionM break-even: Q4/Q1 management expected SessionM to be around break-even initially; it was reported at break-even in both Q1 and Q2. ✅ Delivered
SessionM customer and revenue retention: Q1 cited about $32 million ARR of acquired customer contracts and said customers had agreed to sign Capillary’s paper. Current call cited an approximately $30 million annualized run rate, but did not repeat a retention percentage or confirm every contract status. Partially evidenced
Aira run rate and $10 million ARR objective: Q1 cited a $2–2.5 million run rate and a goal of 5–10% of revenue; Q2 disclosed an $8–9 million pipeline but no updated ARR, and said the $10 million objective may slip by a quarter. ⏳ Delayed / not yet demonstrated
Kognitiv migration: Q1 expected the first customer to go live on 1 September and aimed to complete upgrades by September 2027. Q2 said the first customer had migrated, but did not report broader completion progress. ✅ First migration delivered; overall target still pending
SessionM server-cost reduction: Q2 set a roughly 50% reduction target by March/April. This deadline is still ahead. ⏳ Pending
FY27 revenue and EBITDA: Q1 said the company expected to beat ₹1,065 crore revenue and ₹172 crore adjusted EBITDA; Q2 said it expected to meet or slightly exceed guidance. No FY27 outcome is yet available. ⏳ Pending

Narrative Shifts

From migration-led value to earlier cost actions: Earlier commentary emphasized migrating acquired customers to Capillary’s platform; Q2 stresses that SessionM server-cost improvements can precede full migration.
Aira’s role is broadening: It is no longer framed only as post-acquisition loyalty analytics; it now spans paid acquisition channels and has a standalone sales motion.
Agentic commerce is newly prominent: Management now argues that AI shopping agents may make loyalty economics and real-time performance more important.
Organic acceleration is less certain than sales momentum: New ACV is strong, but management has not raised organic growth guidance and has asked for more quarters of evidence.

Consistency & Credibility Signals

Overall credibility: Medium. Management has been relatively direct about migration duration, SessionM’s lower gross margin and Aira’s possible delay, and several operating claims—such as SessionM break-even—were followed up with current results. However, guidance language has shifted: Q4 FY26 cited FY27 revenue of ₹1,000–1,050 crore, Q1 said it would beat ₹1,065 crore and ₹172 crore EBITDA, and Q2 reverted to meeting or slightly exceeding “guidance” without restating the figures. Aira’s target timing has also softened. These points make the forward outlook less precise even as current-period metrics are positive.

Evolution of Key Themes

Demand / new ACV — Improving: Trailing-12-month new ACV rose from ₹52 crore to ₹93 crore; management cites Aira and stronger deal activity. Organic growth guidance, however, remains guarded.
Margins — Improving: Adjusted EBITDA margin expanded to 17% in H1 from 11% a year earlier; SessionM remains a drag relative to core Capillary.
Acquisition integration — Stable but slow: SessionM is at break-even and cost work is underway, but full migration remains a multi-year effort.
Aira monetization — Improving, timing uncertain: Expanded functionality and a new sales motion are positive, but current ARR was not disclosed and the $10 million target may be delayed.
Capital allocation — Stable: Management remains open to acquisitions but says it will maintain payback and retention discipline.

Additional Insights

Strong headline growth is partly inorganic, while management’s decision not to raise organic guidance signals that ACV momentum has not yet translated into enough proven recurring revenue.
The company’s SessionM margin thesis now has two stages—cost reduction before migration, then further efficiency from migration. The first stage could provide earlier evidence, but the key savings target is still in the future.
Aira is increasingly used as both a sales differentiator for the core platform and a potential standalone product. That broadens its opportunity but makes reported Aira ARR and conversion rates especially important to monitor.

Capillary Holds 20% Organic Growth Guidance Despite ACV Momentum